Analyst Ratings for Trxade Group Inc. (MEDS)

MEDS Rating Summary

  |   Expand Research on MEDS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/26/2021 Maxim Group
» Updated 11/8/2022
Allen Klee New Coverage Buy
(N/A)
2.50
(4.00)
6.28
(7.59)
20.86% Details
12/3/2020 National Securities N/A New Coverage Buy
(N/A)
15.00
(N/A)
5.12
(7.59)
48.24% Details